Chappell, Francesca M.Valdes Hernandez, Maria del CarmenMakin, Stephen D.Shuler, KirstenSakka, EleniDennis, Martin S.Armitage, Paul A.Munoz Maniega, SusanaWardlaw, Joanna M.2020-06-052020-06-052017-02-21Chappell, F M, Valdes Hernandez, M D C, Makin, S D, Shuler, K, Sakka, E, Dennis, M S, Armitage, P A, Munoz Maniega, S & Wardlaw, J M 2017, 'Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study', Trials, vol. 18, 78. https://doi.org/10.1186/s13063-017-1825-71745-6215RIS: urn:92DBF99EAA9664CCE487C080D7A8C27FRIS: 10873ORCID: /0000-0001-8701-9043/work/76976283https://hdl.handle.net/2164/14452We thank the staff of the Brain Research Imaging Centre (http://www.sbirc.ed.ac.uk/) and Neuroimaging Sciences (http://www.ed.ac.uk/clinical-brain-sciences/research/research-methodologies/neuroimaging), University of Edinburgh, but mostly all the participants and relatives who took part in the study. This work was funded by the Wellcome Trust (grant 088134/Z/09/A), Row Fogo Charitable Trust, Age UK, Scottish Funding Council and the Chief Scientist Office of Scotland for the Scottish Imaging Network: A Platform for Scientific Excellence (“SINAPSE”) and the Brain Research Imaging Centre.10494053engWhite matter hyperintensitiesSample size calculationStudy designR MedicineWellcome Trust088134/Z/09/AScottish Funding CouncilScottish Imaging NetworkSINAPSERJournal article10.1186/s13063-017-1825-7https://pubmed.ncbi.nlm.nih.gov/28222778/18